NASDAQ:MNKD

MannKind News Headlines

$4.07
-0.22 (-5.13 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.01
$4.25
50-Day Range
$3.21
$4.83
52-Week Range
$1.14
$6.25
Volume2.92 million shs
Average Volume5.35 million shs
Market Capitalization$1.01 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.28

Headlines

MannKind (NASDAQ MNKD) News Headlines Today

SourceHeadline
MannKind (NASDAQ:MNKD) Cut to Strong Sell at Zacks Investment ResearchMannKind (NASDAQ:MNKD) Cut to Strong Sell at Zacks Investment Research
marketbeat.com - May 6 at 2:18 AM
MannKind Stock Is Believed To Be Significantly Overvalued - Yahoo FinanceMannKind Stock Is Believed To Be Significantly Overvalued - Yahoo Finance
finance.yahoo.com - May 11 at 3:01 AM
MannKind (MNKD) Scheduled to Post Quarterly Earnings on WednesdayMannKind (MNKD) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - May 6 at 12:59 PM
MannKind Co. (NASDAQ:MNKD) Forecasted to Post FY2022 Earnings of ($0.15) Per ShareMannKind Co. (NASDAQ:MNKD) Forecasted to Post FY2022 Earnings of ($0.15) Per Share
americanbankingnews.com - May 6 at 11:12 AM
MannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021 - Yahoo FinanceMannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021 - Yahoo Finance
finance.yahoo.com - May 5 at 1:17 PM
MannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021MannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021
finance.yahoo.com - May 5 at 1:17 PM
Earnings Preview: MannKind (MNKD) Q1 Earnings Expected to Decline - Yahoo FinanceEarnings Preview: MannKind (MNKD) Q1 Earnings Expected to Decline - Yahoo Finance
finance.yahoo.com - April 28 at 2:46 PM
Earnings Preview: MannKind (MNKD) Q1 Earnings Expected to DeclineEarnings Preview: MannKind (MNKD) Q1 Earnings Expected to Decline
finance.yahoo.com - April 28 at 2:46 PM
Receptor Life Sciences Announces Poster Presentations at the Respiratory Drug Delivery 2021 Conference - StreetInsider.comReceptor Life Sciences Announces Poster Presentations at the Respiratory Drug Delivery 2021 Conference - StreetInsider.com
streetinsider.com - April 27 at 8:48 AM
Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer - StreetInsider.comAntares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer - StreetInsider.com
streetinsider.com - April 26 at 9:19 AM
MannKind Reduces Legacy Debt by Approximately $49.5 Million and Restructures Remaining Obligations, including Extended Maturity, Lower Interest Rates and Increased Third Tranche - GlobeNewswireMannKind Reduces Legacy Debt by Approximately $49.5 Million and Restructures Remaining Obligations, including Extended Maturity, Lower Interest Rates and Increased Third Tranche - GlobeNewswire
globenewswire.com - April 26 at 9:19 AM
MannKind Reduces Legacy Debt by Approximately $49.5 Million and Restructures Remaining Obligations, including Extended Maturity, Lower Interest Rates and Increased Third TrancheMannKind Reduces Legacy Debt by Approximately $49.5 Million and Restructures Remaining Obligations, including Extended Maturity, Lower Interest Rates and Increased Third Tranche
finance.yahoo.com - April 26 at 9:19 AM
MNKD June 4th Options Begin Trading - NasdaqMNKD June 4th Options Begin Trading - Nasdaq
nasdaq.com - April 23 at 3:48 AM
MannKind (NASDAQ:MNKD) Stock Price Down 4.1%MannKind (NASDAQ:MNKD) Stock Price Down 4.1%
americanbankingnews.com - April 22 at 12:50 PM
MannKind (NASDAQ:MNKD) Shares Up 2.6%MannKind (NASDAQ:MNKD) Shares Up 2.6%
americanbankingnews.com - April 20 at 1:58 PM
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA - GlobeNewswireMannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA - GlobeNewswire
globenewswire.com - April 19 at 10:35 AM
MannKind Co. (NASDAQ:MNKD) Sees Large Increase in Short InterestMannKind Co. (NASDAQ:MNKD) Sees Large Increase in Short Interest
americanbankingnews.com - April 18 at 3:50 PM
MNKD Apr 2021 2.000 callMNKD Apr 2021 2.000 call
finance.yahoo.com - April 12 at 6:47 PM
3 Biotech Penny Stocks To Watch In April 2021 - StreetInsider.com3 Biotech Penny Stocks To Watch In April 2021 - StreetInsider.com
streetinsider.com - April 7 at 12:26 PM
Global Dry Powder Inhaler Devices Pipeline Assessment Report 2020: Major Players, Product Description, Licensing and Collaboration Details and Developmental Activities - ResearchAndMarkets.com - Business WireGlobal Dry Powder Inhaler Devices Pipeline Assessment Report 2020: Major Players, Product Description, Licensing and Collaboration Details and Developmental Activities - ResearchAndMarkets.com - Business Wire
businesswire.com - April 2 at 12:58 PM
MNKD Apr 2021 7.500 putMNKD Apr 2021 7.500 put
au.finance.yahoo.com - March 29 at 2:07 PM
MannKind Corporation (MNKD) CEO Mike Castagna Presents at Oppenheimers 31st Annual Healthcare Brokers Conference (Transcript) - Seeking AlphaMannKind Corporation (MNKD) CEO Mike Castagna Presents at Oppenheimer's 31st Annual Healthcare Brokers Conference (Transcript) - Seeking Alpha
seekingalpha.com - March 17 at 10:38 PM
MannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes - Yahoo FinanceMannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes - Yahoo Finance
finance.yahoo.com - March 16 at 3:28 PM
MannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior NotesMannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes
finance.yahoo.com - March 16 at 10:27 AM
MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors - GlobeNewswireMannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors - GlobeNewswire
globenewswire.com - March 15 at 6:43 PM
MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors - Yahoo FinanceMannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors - Yahoo Finance
finance.yahoo.com - March 15 at 8:42 AM
MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for SeniorsMannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors
finance.yahoo.com - March 15 at 8:42 AM
MannKind Corporation to Participate in Oppenheimers 31st Annual Healthcare Conference - Yahoo FinanceMannKind Corporation to Participate in Oppenheimer's 31st Annual Healthcare Conference - Yahoo Finance
finance.yahoo.com - March 10 at 9:03 PM
MannKind Corporation to Participate in Oppenheimers 31st Annual Healthcare ConferenceMannKind Corporation to Participate in Oppenheimer's 31st Annual Healthcare Conference
finance.yahoo.com - March 10 at 9:02 PM
MannKind Corporation (MNKD) CEO Michael Castagna Presents at H.C. Wainwright Global Life Sciences Conference (Transcript) - Seeking AlphaMannKind Corporation (MNKD) CEO Michael Castagna Presents at H.C. Wainwright Global Life Sciences Conference (Transcript) - Seeking Alpha
seekingalpha.com - March 10 at 12:13 AM
MannKind (MNKD) Prices Upsized $200.0 Million Convertible Senior Notes Offering - StreetInsider.comMannKind (MNKD) Prices Upsized $200.0 Million Convertible Senior Notes Offering - StreetInsider.com
streetinsider.com - March 3 at 2:57 PM
MNKD stock falls after pricing upsized convertible debt offering - Seeking AlphaMNKD stock falls after pricing upsized convertible debt offering - Seeking Alpha
seekingalpha.com - March 3 at 2:57 PM
MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference - Yahoo FinanceMannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference - Yahoo Finance
finance.yahoo.com - March 3 at 2:57 PM
MannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering - Yahoo FinanceMannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering - Yahoo Finance
finance.yahoo.com - March 3 at 2:57 PM
MannKind Corporation: Bullish On High-Growth Inhaled Insulin Opportunity - Seeking AlphaMannKind Corporation: Bullish On High-Growth Inhaled Insulin Opportunity - Seeking Alpha
seekingalpha.com - March 2 at 5:29 PM
MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences ConferenceMannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 5:29 PM
MannKind Corporation: Bullish On High-Growth Inhaled Insulin OpportunityMannKind Corporation: Bullish On High-Growth Inhaled Insulin Opportunity
seekingalpha.com - March 2 at 2:21 PM
MannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering - GlobeNewswireMannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering - GlobeNewswire
globenewswire.com - March 2 at 7:29 AM
MannKind stock lower after $150M convertible debt offering - Seeking AlphaMannKind stock lower after $150M convertible debt offering - Seeking Alpha
seekingalpha.com - March 2 at 7:29 AM
MannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes OfferingMannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering
finance.yahoo.com - March 2 at 7:29 AM
MannKind (MNKD) Announces Proposed Private Placement of Convertible Senior Notes - StreetInsider.comMannKind (MNKD) Announces Proposed Private Placement of Convertible Senior Notes - StreetInsider.com
streetinsider.com - March 2 at 1:25 AM
MannKind stock lower after $150M convertible debt offeringMannKind stock lower after $150M convertible debt offering
seekingalpha.com - March 1 at 10:40 AM
MannKind Corporation Announces Proposed Private Placement of Convertible Senior Notes - Yahoo FinanceMannKind Corporation Announces Proposed Private Placement of Convertible Senior Notes - Yahoo Finance
finance.yahoo.com - March 1 at 8:45 AM
MannKind Corporation Announces Proposed Private Placement of Convertible Senior NotesMannKind Corporation Announces Proposed Private Placement of Convertible Senior Notes
finance.yahoo.com - March 1 at 8:45 AM
What Does MannKinds Debt Look Like? - BenzingaWhat Does MannKind's Debt Look Like? - Benzinga
benzinga.com - February 28 at 2:05 PM
What Does MannKinds Debt Look Like?What Does MannKind's Debt Look Like?
finance.yahoo.com - February 26 at 5:54 PM
Edited Transcript of MNKD.OQ earnings conference call or presentation 25-Feb-21 2:00pm GMT - Yahoo FinanceEdited Transcript of MNKD.OQ earnings conference call or presentation 25-Feb-21 2:00pm GMT - Yahoo Finance
finance.yahoo.com - February 26 at 7:53 AM
MannKind Corporation (MNKD) CEO Michael Castagna on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaMannKind Corporation (MNKD) CEO Michael Castagna on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 26 at 7:53 AM
MannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript - Motley FoolMannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript - Motley Fool
fool.com - February 26 at 2:52 AM
MannKind Corporation (MNKD) Q4 2020 Earnings Call TranscriptMannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript
fool.com - February 26 at 1:14 AM
MannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results - Yahoo FinanceMannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results - Yahoo Finance
finance.yahoo.com - February 25 at 11:50 AM
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.